Signaling mechanisms through gp130: A model of the cytokine system

Cytokine and Growth Factor Reviews

Volumn 8, Issue 4, 1997, Pages 241-252

  Hirano, Toshio ^a   Nakajima, Koichi ^a   Hibi, Masahiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cytokine; Gp130; Interleukin 6; Receptor; Signal transduction

Indexed keywords

CELL RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; GP130 SIGNAL TRANSDUCER; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL DIVISION; CELL MEMBRANE; CELL NUCLEUS; CHEMISTRY; CYTOPLASM; ENZYME ACTIVATION; HUMAN; IMMUNOMODULATION; LIGAND BINDING; NONHUMAN; PHYSIOLOGY; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; TARGET CELL;

ANIMALIA;

EID: 0031429943     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(98)80005-1     Document Type: Short Survey

References (139)

1. 1. Hirano, T., Yasukawa, K., Harada, H. et al., Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature, 1986, 324, 73-76.
2. 2. Zilberstein, A., Ruggieri, R., Korn, J. H. and Revel, M.. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J., 1986, 5, 2529-2537.
3. 3. Haegeman, G., Content, J., Volckaert, G., Derynck, R., Tavernier, J. and Fiers, W., Structural analysis of the sequence encoding for an inducible 26-kDa protein in human fibroblasts. Eur. J. Biochem., 1986, 159, 625-632.
4. 2 interferon involved. Proc. Natl Acad. Sci. USA., 1986, 83, 8957-8961.
5. 5. Sehgal, P. B., Grienger, G. and Tosato, G., ed. Regulation of the acute phase and immune responses: Inlerleukin-6. 1989. Ann. New York Acad. Sci., Vol. 557.
6. 6. Hirano, T. and Kishimoto, T., Interleukin 6. Peptide growth factors and their receptors. In Handbook of Experimental Pharmacology. Vol. 95/1, eds M. B. Sporn and A. B. Roberts, Springer-Verlag. Berlin, 1990, pp. 633-665.
7. 7. Hirano, T., Matsuda, T. and Nakajima, K., Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokiue subfamily. Stem Cells, 1994, 12, 262-277.
8. 8. Mackiewicz, A., Koj, A. and Sehgal. P. B., ed. Interleukin-6-type cytokines. Ann. New York Acad. Sci., Vol. 762. New York, 1995.
9. 9. Gearing, D., Gough, N. M., King, J. A. et al., Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J., 1987, 6, 3995-4002.
10. 10. Lin, L.-F. H., Mismer, D., Lile, J. D. et al., Purification, cloning and expression of ciliary neurotrophic factor (CNTF). Science, 1989, 246, 1023-1025.
11. 11. Malik, N., Kalestad, J. C., Gunderson, N. L. et al., Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol. Cell. Biol., 1989, 9, 2847-2853.
12. 12. Paul, S. R., Bennett, F., Calvetti, J. A. et al., Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl Acd. Sci. USA., 1990, 87, 7512-7516.
13. 13. Pennica, D., King, K. L., Shaw, K. L. et al., Expression cloning of cardiotrophin-1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl Acad. Sci. USA., 1995, 92, 1142-1146.
14. 14. Hirano, T., Interleukin 6 and its receptor: ten years later. Intern Rev. Immunol., in press.
15. 15. Metcalf, D., The leukemia inhibitory factor (LIF). Int. J. Cell Cloning, 1991, 9, 95-108.
16. 16. Patterson, P. H. and Nawa, H., Neuronal differentiation factors/cytokines and synaptic plasticity. Cell, 1993, 72, 123-137.
17. 17. Pennica, D., Wood, W. I. and Chien, K. R., Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp130 dependent pathways. Cytokine Growth Factor Rev., 1996, 7, 81-91.
18. 18. Kishimoto, T., Akira, S., Narazaki, M. and Taga. T., Interleukin-6 family of cytokines and gp130. Blood, 1995, 86, 1243-1254.
19. 19. Hirano, T., The biology of interleukin-6. Chem. Immunol., 1992, 51, 153-180.
20. 20. Hilton, D. J., LIF: lots of interesting functions. Trends Biochem. Sci., 1992, 17, 72-76.
21. 21. Yang, Y. C., Interleukin 11: an overview. Stem Cells, 1993, 11, 474-486.
22. 22. Ip, N. Y. and Yancopoulos G. D., The neurotrophins and CNTF: two families of collaborative neurotrophic factors. Ann. Rev. Neurosci., 1996, 19, 491-515.
23. 23. Gearing, D. P.. The leukemia inhibitory factor and its receptor. Adv. Immunol., 1993, 53, 31-58.
24. 24. Hibi, M., Nakajima, K. and Hirano, T., IL-6 cytokine family and signal transduction: a model of the cytokine system. J. Mol. Med., 1996, 74, 1-12.
25. 25. Ihle, J. N., Witthuhn, B. A., Quelle, F. W. et al., Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci., 1994, 19, 222-227.
26. 26. Darnell, J. J., Kerr, I. M. and Stark, G. R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 1994, 264, 1415-1421.
27. 27. Schindler, C. and Darnell, J. E., Jr., Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu. Rev. Biochem., 1995, 64, 621-651.
28. 28. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K. and Silvennoinen, O., Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol., 1995, 13, 369-398.
29. 29. Davis, S. and Yancopoulos, G. D., The molecular biology of the CNTF receptor. Curr. Opin. Cell Biol., 1993, 5, 281-285.
30. 30. Yamasaki, K., Taga, T., Hirata, Y. et al., Cloning and expression of the human interleukin-6 (BSF-2/1FN beta 2) receptor. Science, 1988, 241, 825-828.
31. 31. Taga, T., Hibi, M., Hirata, Y. et al., Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell, 1989, 58, 573-581.
32. 32. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T. and Kishimoto, T., Molecular cloning and expression of an IL-6 signal transducer. gp130. Cell, 1990, 63, 1149-1157.
33. 33. Bazan, J. F., Haemopoietic receptors and helical cytokines. Immunol. Today, 1990, 11, 350-354.
34. 34. Sugita, T., Totsuka, T., Saito, M. et al., Functional murine interleukin 6 receptor with the intracisternal A particle gene product at is cytoplasmic domain. Its possible role in plasmacytomagenesis. J. Exp. Med., 1990, 171(6), 2001-2009.
35. 35. Ward, L. D., Howlett, G. J., Discolo, G. et al., High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J. Biol. Chem., 1994, 269, 23,286-23,289.
36. 36. Paonessa, G., Graziani, R., Serio, A. D. et al., Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. EMBO J., 1995, 14, 1942-1951.
37. 37. Miyajima, A., Kitamura, T., Harada, N., Yokota, T. and Arai, K., Cytokine receptors and signal transduction. Annu. Rev. Immunol., 1992, 10, 295-339.
38. 38. Sugamura, K., Asao, H., Kondo, M. et al., The common gamma-chain for multiple cytokine receptors. Adv. Immunol., 1995, 59, 225-227.
39. 39. Taniguchi, T., Cytokine signaling through nonreceptor protein tyrosine kinase. Science, 1995, 268, 251-255.
40. 40. Kobayashi, M., Fitz, L., Ryan, M. et al., Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med., 1989, 170, 827-845.
41. 41. Gearing, D. P. and Cosman, D., Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell, 1991, 66, 9-10.
42. 42. Chua, A. O., Chizzonite, R., Desai, B. B. et al., Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp120. J. Immunol., 1994, 153, 128-136.
43. 43. Davis, S., Aldrich, T. H., Ip, N. Y. et al., Released form of CNTF receptor a components as a soluble mediator of CNTF responses. Science, 1993, 259, 1736-1739.
44. 44. Baumann, H., Wang, Y., Morella, K. K. et al.. Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J. Immunol., 1996, 157, 284-290.
45. 45. Nedderman, P., Graziani, R., Ciliberto, G. and Paonessa, G., Functional expression of soluble human interleukin-11 (IL-11) receptor alpha and stoichiometry of in vitro IL-11 receptor complexes with gp130. J. Biol. Chem., 1996, 271, 30,986-30,991.
46. 46. Hirano, T., Interleukin 6. In The Cytokine Handbook, 2nd edn, ed. A. W. Thomson. Academic Press, London, 1994, pp. 145-168.
47. 47. Hirota, H., Yoshida, K., Kishimoto, T. and Taga, T., Continuous activation of gp130, a signal transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl Acad. Sci. USA., 1995, 92, 4862-4866.
48. 48. Peters, M., Schirmacher, P., Goldschmitt, J. et al., Extra-medullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J. Exp. Med., 1997, 185, 755-766.
49. 49. Treanor, J. J. S., Goodman, L., de Sauvage, F. et al.. Characterization of a multicomponent receptor for GDNF. Nature, 1996, 382, 80-83.
50. 50. Jing, S., Wen, D., Yu, Y. et al., GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell, 1996, 85, 1113-1124.
51. 51. Klein, R. D., Sherman, D., Ho, W.-H. et al., A GPI-linked protein that interacts with Ret form a candidate neurturin receptor. Nature, 1997, 387, 717-721.
52. 52. Buj-Bello, A., Adu, J., Pinon, L. G. P. et al., Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature, 1997, 387, 721-724.
53. 53. Fisher, M., Goldschmitt, J., Peschel, C. et al., A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nature Biotechnology, 1997, 15, 142-145.
54. 54. Velazquez, L., Fellous, M., Stark, G. R. and Pellegrini, S. A protein tyrosine kinase in the interferon a/b signaling pathway. Cell, 1992, 70, 313-322.
55. 55. Witthuhn, B. A., Quelle, F. W., Silvennoinen, O. et al., Jak2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell, 1993, 74, 227-236.
56. 56. Argetsinger, L. S., Campbell, G. S., Yang, X. et al., Identification of Jak2 as a growth hormone receptor-associated tyrosine kinase. Cell, 1993, 74, 237-244.
57. 57. Lutticken, C., Wegenka, U. M., Yuan, J. et al., Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science, 1994, 263, 89-92.
58. 58. Stahl, N., Boulton, T. G., Farruggella, T. et al., Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science, 1994, 263, 92-95.
59. 59. Matsuda, T., Yamanaka, Y. and Hirano, T., Interleukin-6-induced tyrosine phosphorylation of multiple proteins in murine hematopoietic lineage cells. Biochem. Biophys. Res. Commun., 1994, 200, 821-828.
60. 60. Berger, L. C., Hawley, T. S., Lust, J. A., Goldman, S. J. and Hawley, R. G., Tyrosine phosphorylation of JAK-TYK kinases in malignant plasma cell lines growth-stimulated by interleukins 6 and 11. Biochem. Biophys. Res. Commun., 1994, 202, 596-605.
61. 61. Guschin, D., Rogers, N., Briscoe, J. et al., A major role for the protein kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J., 1995, 14, 1421-1429.
62. 62. Akira, S., Nishio, Y., Inoue, M. et al., Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell, 1994, 77, 63-71.
63. 63. Zhong, Z., Wen, Z. and Darnell, J. E., Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science, 1994, 264, 95-98.
64. 64. Fujitani, Y., Nakajima, K., Kojima, H., Nakae, K., Takeda, T. and Hirano, T., Transcriptional activation of the IL-6 response element in the junB promoter is mediated by multiple Stat family proteins. Biochem. Biophys. Res. Commun., 1994, 202, 1181-1187.
65. 65. Nakajima, K., Matsuda, T., Fujitani, Y. et al., Signal transduction through IL-6 receptor: involvement of multiple protein kinases, stat factors, and a novel H7-sensitive pathway. Ann N. Y. Acad. Sci., 1995, 762, 55-70.
66. 66. Lai, C. F., Ripperger, J., Morella, K. K. et al., STAT3 and STAT5B are targets of two different signal pathways activated by hematopoictin receptors and control transcription via separate cytokine response elements. J. Biol. Chem., 1995, 270, 23,254-23,257.
67. 67. Fujitani, Y., Hibi, M., Fukada, T. et al., An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT. Oncogene, 1997, 14, 751-761.
68. 68. Akira, S., Isshiki, H., Sugita, T. et al., A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J., 1990, 9, 1897-1906.
69. 69. Poli, V., Mancini, F. P. and Cortese, R., IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell, 1990, 63, 643-653.
70. 70. Wegenka, U. M., Buschmann, J., Lutticken, C., Heinrich, P. C. and Horn, F., Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interieukin-6 at the posttranslational level. Mol. Cell. Biol., 1993, 13, 276-288.
71. 71. Nakajima, K., Kusafuka, T., Takeda, T., Fujitani, Y., Nakae, K. and Hirano, T., Identification of a novel interleukin-6 response element containing an Ets-binding site and a CRE-like site in the junB promoter. Mol. Cell. Biol., 1993, 13, 3027-3041.
72. 72. Kojima, H., Nakajim, K. and Hirano, T., IL-6-inducible complexes on an IL-6 response element of the junB promoter contain Stat3 and 36 kDa CRE-like site binding protein(s). Oncogene, 1996, 12, 547-554.
73. 73. Zhang, X., Blenis, J., Li, H. C., Schindler, C. and Chen, K. S., Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science, 1995, 267, 1990-1994.
74. 74. Wen, Z., Zhong, Z. and Darnell, J. E., Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell, 1995, 82, 241-250.
75. 75. David, M., Petricoin, E. R., Benjamin, C., Pine, R., Webber, M. J. and Larner, A. C., Requirement for MAP kinase (ERK2) activity in interferon alpha-and interferon beta-stimulated gene expression through STAT proteins [see comments]. Science, 1995, 269, 1721-1723.
76. 76. Pfeffer, L. M., Mullersman, J. E., Pfeffer, S. R., Murti, A., Shi, W. and Yang, C. H., Stat3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science, 1997, 276, 1418-1420.
77. 77. Sekimoto, T., Nakajima, K., Tachibana, T., Hirano, T. and Yoneda, Y., Interferon-gamma-dependent nuclear import of Stat1 is mediated by the GTPase activity of Ran/TC4. J. Biol. Chem., 1996, 271, 31,017-31,020.
78. 78. Boutton, T. G., Stahl, N. and Yancopoulos, G. D., Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem., 1994, 2696, 11,648-11,655.
79. 79. Fuhrer, D. K., Feng, G. S. and Yang, Y. C., Syp associates with gp130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse preadipocytes. J. Biol. Chem., 1995, 270, 24,826-24,830.
80. 80. Fukada, T., Hibi, M., Yamanaka, Y. et al., Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Manuscript submitted. Immunity, 1996, 5, 449-460.
81. 81. Nakafuku, M., Satoh, T. and Kaziro, Y., Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6 induce an accumulation of an active Ras.GTP complex in rat pheochromocytoma PC12 cells. J. Biol. Chem., 1992, 267, 19,448-19,454.
82. 82. Yin, T. and Yang, Y. C., Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J. Biol. Chem.. 1994, 269, 3731-3738.
83. 83. Kumar, G., Gupta, S., Wang, S. and Nel, A. E., Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth-responsive B cell line. J. Immunol., 1994. 153, 4436-4447.
84. 84. Berger, L. C. and Hawley, R. G., Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells. Blood, 1997, 89, 261-271.
85. 85. Daeipour, M., Kumar, G., Amaral, M. C. and Nel, A. E., Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line. AF-10. J. Immunol., 1993, 150, 4743-4753.
86. 86. Ernst, M., Oates, A. and Dunn, A. R. Gp130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. J. Biol. Chem., 1996, 271, 30,136-30,143.
87. 87. Ernst, M., Gearing, D. P. and Dunn, A. R., Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J., 1994, 13, 1574-1584.
88. 88. Matsuda, T., Takahashi Tezuka, MS., Fukada, T. et al., Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood, 1995, 85, 827-633.
89. 89. Matsuda, T., Fukada, T., Takahashi Tezuka, M. et al., Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J. Biol. Chem., 1995, 270, 11,037-11,039.
90. 90. Takahashi-Tezuka, M., Hibi, M., Fujitani, Y., Fukada, T., Yamaguchi, T. and Hirano, T., Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. Oncogene, 1997, 14, 2273-2282.
91. 91. Fukunaga, R., Ishizaka Ikeda, E., Pan, C. W., Seto, Y. and Nagata, S., Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J., 1991, 10, 2855-2865.
92. 92. Murakami, M., Narazaki, M., Hibi, M. et al., Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc. Natl Acad. Sci. USA., 1991, 88, 11,349-11,353.
93. 93. Narazaki, M., Witthuhn, B. A., Yoshida, K. et al., Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc. Natl Acad. Sci. USA., 1994, 9181(6470), 2285-2289.
94. 94. Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E., Jr and Yancopoulos, G. D., Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science, 1995, 267(5205), 1349-1353.
95. 95. Holgado-Madruga, M., Emlet, D. R., Mosacatello, D. K., Godwin, A. K. and Wang, A. J., Grb2-associated docking protein in EGF-and insulin-receptor signalling. Nature, 1996, 319, 560-564.
96. 96. Weidner, K. M., Di-Cesare, S., Sachs, M., Brinkmann, V., Behrens, J. and Birchmeier W., Interaction between Gab1 and c-Met receptor tyrosine kinase is responsible for epithelial morphogenes. Nature, 1996, 384, 173-176.
97. 97. Keegan, A. D., Nelms, K., White, M., Wang, L.-M. and Pierce, J. H., E. PW. An IL-4 receptor regin containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell, 1994. 76, 811-820.
98. 98. Johnston, J. A., Wang, L. M., Hanson, E. P. et al., Interleukin 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insuline receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J. Biol. Chem., 19??, 270, 28,527-28,530.
99. 99. Burfoot, M. S., Rogers, N. C., Watling, D. et al., JAK-dependent activation of IRS-1 in response to IL-4, Oncostatin M and the interferons. J. Biol. Chem., 1997.
100. 100. Yin, T., Keller, S. R., Quelle, F. W. et al., Interleukin-9 induces tyrosine phosphoryiation of insulin receptor substrate-1 via JAK tyrosine kinases. J. Biol. Chem., 1995, 270, 20,497-20,502.
101. 101. Argetsinger, L. S., Norstedt, G., Billestrup, N., White, M. F. and Carter Su, C., Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J. Biol. Chem., 1996, 271, 29,415-29,421.
102. 102. Yamanaka, Y., Nakajima, K., Fukada, T., Hibi, M. and Hirano, T., Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J., 1996, 15(7), 1557-1565.
103. 103. Baumann, H., Symes, A. J., Comeau, M. R. et al., Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol. Cell. Biol., 1994, 14, 138-146.
104. 104. Rincon, M., Anguita, J., Nakamura, T., Fikrig, E. and Flavell, R. A., Interleukin (IL)-6 directs the differentiation of IL-4-producingCD4+ T cells. J. Exp. Med., 1997, 185, 461-469.
105. 105. Shabo, Y., Lotem, J., Rubinstein, M. et al., The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin 6. Blood, 1988, 72, 2070-2073.
106. 106. Miyaura, C., Onozaki, K., Akiyama, Y. et al., Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1). FEBS Lett., 1988, 234, 17-21.
107. 107. Oritani, K., Kaisho, T., Nakajima, K. and Hirano, T., Retinoic acid inhibits interleukin-6-induced macrophage differentiation and apoptosis in a murine hematopoietic cell line, Y6. Blood, 1992, 80, 2298-2305.
108. 108. Satoh, T., Nakamura, S., Taga, T. et al., Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol. Cell. Biol., 1988, 8, 3546-3549.
109. 109. Nordan, R. P. and Potter, M., A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science, 1986, 233, 566-569.
110. 110. Kawano, M., Hirano, T., Matsuda, T. et al., Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, 1988, 332, 83-85.
111. 111. Van Snick, J., Cayphas, S., Szikora, J. P. et al., cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur. J. Immunol., 1988, 18, 193-197.
112. 112. Hirano, T., Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias. Int. J. Cell Cloning, 1991, 9, 166-184.
113. 113. Nakajima, K., Yamanaka, Y., Nakae, K. et al., A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J., 1996, 15, 3651-3658.
114. 114. Minami, M., Inoue, M., Wei, S. et al., STAT3 activation is a critical step in gp1430-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acd. Sci. USA., 1996, 93, 3963-3966.
115. 115. Shimozaki, K., Nakajima, K., Hirano, T. and Nagata, S., Involvement of STAT3 in the granulocyte colony stimulating factor-induced differentiation of myeloid cells. J. Biol. Chem., 1997, 272, 25184-25189.
116. 116. Chin, Y. E., Kilagawa, M., Su, W. C., You, Z. H., Iwamoto, Y. and Fu, X. Y., Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science, 1996, 272, 719-722.
117. 117. Morse, L., Chen, D., Franklin, D., Yue Xiong and Chen-King. S., Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18INK4c and IL-6. Immunity, 1997, 6, 47-56.
118. 118. Billadeau, D., Jelinek, D. F., Shah, N., LeBien, T. W. and Van Ness, B. Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6. Cancer Res., 1995. 55, 3640-3646.
119. 119. Schwarze, M. M. and Hawley, R. G. Prevention of myeloma cell apoptosis by ectopic bc1-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res., 1995, 55, 2262-2265.
120. 120. Wu, Y. Y. and Bradshaw, R. A., Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant PC12 cell (E2) line. J. Biol. Chem., 1996, 271, 13,023-13,032.
121. 121. Ihara, S., Iwamatsu, A., Fujiyoshi, T., Komii, A., Yamor, T. and Fukui, Y., Identification of interleukin-6 as a factor that induces neurite outgrowth by PC12 cells primed with NGF. J. Biochem., 1996, 120, 865-868.
122. 122. Sterneck, E., Kaplan, D. R. and Johnson, P. F., Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells. J. Neurochem., 1996, 67, 1365-1374.
123. 123. Ihara, S., Nakajima, K., Fukada, T. et al., Dual control of neurite outgrowth by STAT3 and MAP kinase in PC12 cells stimulated with interleukin-6. EMBO J., 1997, 16, 5345-5352.
124. 124. Boeuf, H., Hauss, C., De Graeve, F., Baran, N. and Kedinger, C., LIF-dependent transcriptional activation in embryonic stem cells. J. Cell. Biology, 1997, 138, 1207-1217.
125. 125. Ihle, J. N., STATs: Signal transducers and activators of transcription. Cell, 1996, 84, 331-334.
126. 126. O'Shea, J. J., Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity, 1997, 7, 1-11.
127. 127. Liu, Z. G., Hsu, H., Goeddel, D. V. and Karin, M., Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell, 1996, 87, 565-576.
128. 128. Qui, M. S. and Green, S. H., PC12 cell neuronal differentiation is associated with prolonged p21 ras activity and consequent prolonged ERK activity. Neuron, 1992, 9, 705-717.
129. 129. Traverse, S., Gomez, N., Paterson, H., Marshall, C. and Cohen, P., Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J., 1992, 288, 351-355.
130. 130. Haspel, R. L., Salditt Georgieff, M. and Darnell, J. E., Jr., The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J., 1996, 15, 6262-6268.
131. 131. Caldenhoven, E., van Dijk, T. B., Solari, R. et al., STAT-3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J. Biol. Chem., 1996, 271, 13,221-13,227.
132. 132. Wang, D., Stravopodis, D., Teglund, S., Kitazawa, J. and Ihle, J. N., Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol., 1996, 16, 6141-6148.
133. 133. Klingmuller, U., Lorenz, U., Cantley. L. C., Neel, B. G. and Lodish, H. F., Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell, 1995, 80, 729-738.
134. 134. Ali, S., Chen, Z., Lebrun, J. J. et al., PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation. EMBO J., 1996, 15, 135-142.
135. 135. Kharitonenkov, A., Chen, Z., Sures, I., Wang, H., Schilling, J. and Ullrich, A., A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature, 1997, 386, 181-186.
136. 136. Fujioka, Y., Matozaki, T., Noguchi, T. et al., A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol. Cell. Biol., 1996, 16, 6887-6899.
137. 137. Starr, R., Willson, T. A., Viney, E. M. et al., A family of cytokine-inducible inhibitors of signalling. Nature, 1997, 387, 917-921.
138. 138. Endo. T. A., Masuhara, M., Yokouchi, M. et al., A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 1997, 387, 921-924.
139. 139. Naka, T., Narazaki, M., Hirata, M. et al., Structure and function of a new STAT-induced STAT inhibitor. Nature, 1997, 387, 924-929.